General Announcement::Disclosure

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PH US$200M4.5%210802 - XS1456577334 - 4N4B
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
11-Aug-2018 00:07:43
Status
New
Announcement Sub Title
Disclosure
Announcement Reference
SG180811OTHRVTLU
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Ltd.
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
10/08/2018 17:00:00
Description (Please provide a detailed description of the event in the box below)
Disclosure

Attachments

SGX_Ortho.pdf
Total size =1255K